Appendix 2A - Application for quotation of securities Announcement Summary Entity name PERCHERON THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Friday November 06, 2026 The +securities to be quoted are: Other Please refer to the response to Q2.3d for further...
Application for quotation of securities - PER
Filed with ASX · · 7 pages · English
Summary by 6ix AI
Percheron Therapeutics Limited has filed an application for the quotation of new securities on the ASX, specifically options exercisable at a set price before a specified date. The application also notes that the entity has obtained security holder approval for this issue under the relevant listing rule.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Notification regarding unquoted securities - PER
- Update - Proposed issue of securities - PER
- Prospectus - Placement options and JLM options
- FDA Clearance for Vanderbilt Health Clinical Trial in AML
- Listing Rule waiver to allow quotation of PERAQ options
Later from Percheron Therapeutics
- Top 20 Optionholders and Distribution List
- Change of Director's Interest Notice
- Updated Top 20 Option Holders Report
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics